- Home
- MLGO vs CLRB Comparison
MLGO vs CLRB Comparison
Compare MLGO & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- CLRB
- Stock Information
- Founded
- MLGO 2018
- CLRB 2002
- Country
- MLGO China
- CLRB United States
- Employees
- MLGO N/A
- CLRB N/A
- Industry
- MLGO EDP Services
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- MLGO Technology
- CLRB Health Care
- Exchange
- MLGO Nasdaq
- CLRB Nasdaq
- Market Cap
- MLGO 16.0M
- CLRB 15.3M
- IPO Year
- MLGO N/A
- CLRB N/A
- Fundamental
- Price
- MLGO $6.36
- CLRB $0.31
- Analyst Decision
- MLGO
- CLRB Buy
- Analyst Count
- MLGO 0
- CLRB 2
- Target Price
- MLGO N/A
- CLRB $28.00
- AVG Volume (30 Days)
- MLGO 32.9M
- CLRB 1.4M
- Earning Date
- MLGO 02-28-2025
- CLRB 03-26-2025
- Dividend Yield
- MLGO N/A
- CLRB N/A
- EPS Growth
- MLGO N/A
- CLRB N/A
- EPS
- MLGO N/A
- CLRB N/A
- Revenue
- MLGO $83,504,125.00
- CLRB N/A
- Revenue This Year
- MLGO N/A
- CLRB N/A
- Revenue Next Year
- MLGO N/A
- CLRB N/A
- P/E Ratio
- MLGO N/A
- CLRB N/A
- Revenue Growth
- MLGO 643.57
- CLRB N/A
- 52 Week Low
- MLGO $1.11
- CLRB $0.22
- 52 Week High
- MLGO $509.60
- CLRB $4.45
- Technical
- Relative Strength Index (RSI)
- MLGO 86.06
- CLRB 46.10
- Support Level
- MLGO $1.11
- CLRB $0.26
- Resistance Level
- MLGO $1.34
- CLRB $0.35
- Average True Range (ATR)
- MLGO 0.76
- CLRB 0.03
- MACD
- MLGO 0.35
- CLRB 0.02
- Stochastic Oscillator
- MLGO 49.53
- CLRB 61.40
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments Central processing algorithm services & Intelligent chips and services. The majority is from the Central processing algorithm services. which refer to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.